‘Vande Bharat’: 84 of 141 new repatriation flights for Kerala; only 1 for Karnataka

Bengaluru, Mar 7: Karnataka Chief Minister BS Yediyurappa on Friday said that the Upper Krishna Project (UKP) will be completed within the next three years.

Speaking in the Assembly, the Chief Minister said: "After discussing with the officials of the finance department, we have decided to allocate Rs 10,000 crore funds for the third phase of UKP. This project will be completed within a span of three years."

Yediyurappa also said that the government will hold talks for additional funds from the Central government.

The leader of Opposition, Siddaramaiah, interrupted and said that the CM has announced this just to gain the confidence of MLAs from north Karnataka.

"The government could have announced it in the budget itself or else the Chief Minister could have announced it at the time of discussion on the budget. Where are the funds with the government to complete the project? CM has announced this just to gain the confidence of MLAs who hail from north Karnataka," said Siddaramaiah.

Deputy Chief Minister Govinda Karajol while speaking to the media welcomed the Chief Minister's statement and said that the earlier government didn't allocate a single penny in the last seven years he added.

Bengaluru, Mar 3: Minister of Medical Education K Sudhakar on Tuesday said that there is no need to panic as appropriate measures have been taken by the state government to tackle a possible Coronavirus outbreak.

"I request the media not to spread panic and support the government in dealing with any possible Coronavirus outbreak. With the help of the Centre we have taken all required precautionary measures to deal with any situation," Sudhakar told reporters.

Talking about the first confirmed case in Telangana, who had stopped over in Bengaluru, the Minister said, "His flatmates and 23 people who travelled with him from Karnataka are being screened. Both the state (Karnataka and Telangana) government are taking care of them."

"Out of the 295 samples collected so far, 240 tested samples tested negative. We are awaiting more results as of now. There are two labs. One in RGICS and another in Bangaluru Medical College where tests are being carried out," he said.

On Monday, the first confirmed case of a Novel Coronavirus in Telangana was reported from Hyderabad when a 24-year-old man, who had come in contact with some Hong Kong citizens, while he was in Dubai on February 17, tested positive for the virus.

After arriving in Bengaluru on February 20 and travelled to Hyderabad by bus on February 22.

Meanwhile, Telangana Health Minister Eatala Rajender on Sunday said that the state government is on a high alert since the confirmation of one Coronavirus positive case here.

The Health Department has also issued an advisory to all educational institutes.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.